154 related articles for article (PubMed ID: 35147227)
21. A Systematic Review of Procedural Complications from Transforaminal Lumbar Puncture for Intrathecal Nusinersen Administration in Patients with Spinal Muscular Atrophy.
Grayev A; Schoepp M; Kuner A
AJNR Am J Neuroradiol; 2021 May; 42(5):980-985. PubMed ID: 33632735
[TBL] [Abstract][Full Text] [Related]
22. Ultrasound-guided nusinersen administration for spinal muscular atrophy patients with severe scoliosis: an observational study.
Zhang J; Cui X; Chen S; Dai Y; Huang Y; Zhang S
Orphanet J Rare Dis; 2021 Jun; 16(1):274. PubMed ID: 34120632
[TBL] [Abstract][Full Text] [Related]
23. Unilateral interlaminar fenestration on the convex side provides a reliable access for intrathecal administration of nusinersen in spinal muscular atrophy: a retrospective study.
Wang Z; Feng E; Jiao Y; Zhao J; Chen X; Zhang H; Liang J; Li Z; Cui X; Chen W; Shen J
Orphanet J Rare Dis; 2023 Nov; 18(1):369. PubMed ID: 38031122
[TBL] [Abstract][Full Text] [Related]
24. Nusinersen for Patients With Spinal Muscular Atrophy: 1415 Doses via an Interdisciplinary Institutional Approach.
Madan E; Carrié S; Donado C; Lobo K; Souris M; Laine R; Beers E; Cornelissen L; Darras BT; Koka A; Riley B; Dinakar P; Stone S; Snyder B; Graham RJ; Padua H; Sethna N; Berde C
Pediatr Neurol; 2022 Jul; 132():33-40. PubMed ID: 35636280
[TBL] [Abstract][Full Text] [Related]
25. Administration of nusinersen via paramedian approach for spinal muscular atrophy.
Iwayama H; Wakao N; Kurahashi H; Kubota N; Hattori A; Kumagai T; Okumura A
Brain Dev; 2021 Jan; 43(1):121-126. PubMed ID: 32773161
[TBL] [Abstract][Full Text] [Related]
26. Intrathecal catheter and port placement for nusinersen infusion in children with spinal muscular atrophy and spinal fusion.
Shashi KK; Stone SSD; Berde CB; Padua HM
Pediatr Radiol; 2021 Dec; 51(13):2588-2595. PubMed ID: 34254153
[TBL] [Abstract][Full Text] [Related]
27. Intrathecal nusinersen administration in adult spinal muscular atrophy patients with complex spinal anatomy.
Cordts I; Lingor P; Friedrich B; Pernpeintner V; Zimmer C; Deschauer M; Maegerlein C
Ther Adv Neurol Disord; 2020; 13():1756286419887616. PubMed ID: 32010224
[TBL] [Abstract][Full Text] [Related]
28. Nusinersen Administration Via an Intrathecal Port in a 16-Year-Old Spinal Muscular Atrophy Patient with Profound Scoliosis.
Flotats-Bastardas M; Linsler S; Zemlin M; Meyer S
Pediatr Neurosurg; 2020; 55(1):54-57. PubMed ID: 31722365
[TBL] [Abstract][Full Text] [Related]
29. An Integrated Safety Analysis of Infants and Children with Symptomatic Spinal Muscular Atrophy (SMA) Treated with Nusinersen in Seven Clinical Trials.
Darras BT; Farrar MA; Mercuri E; Finkel RS; Foster R; Hughes SG; Bhan I; Farwell W; Gheuens S
CNS Drugs; 2019 Sep; 33(9):919-932. PubMed ID: 31420846
[TBL] [Abstract][Full Text] [Related]
30. Nusinersen: A Review in 5q Spinal Muscular Atrophy.
Hoy SM
CNS Drugs; 2021 Dec; 35(12):1317-1328. PubMed ID: 34850360
[TBL] [Abstract][Full Text] [Related]
31. Scoliosis and spinal muscular atrophy in the new world of medical therapy: providing lumbar access for intrathecal treatment in patients previously treated or undergoing spinal instrumentation and fusion.
Labianca L; Weinstein SL
J Pediatr Orthop B; 2019 Jul; 28(4):393-396. PubMed ID: 30932967
[TBL] [Abstract][Full Text] [Related]
32. Transforaminal lumbar puncture for spinal anesthesia or novel drug administration: a technique combining C-arm fluoroscopy and ultrasound.
Berde C; Formanek A; Khan A; Camelo CR; Koka A; Riley BL; Padua H
Reg Anesth Pain Med; 2022 Jun; 47(6):380-383. PubMed ID: 35321920
[TBL] [Abstract][Full Text] [Related]
33. Preliminary Safety and Tolerability of a Novel Subcutaneous Intrathecal Catheter System for Repeated Outpatient Dosing of Nusinersen to Children and Adults With Spinal Muscular Atrophy.
Strauss KA; Carson VJ; Brigatti KW; Young M; Robinson DL; Hendrickson C; Fox MD; Reed RM; Puffenberger EG; Mackenzie W; Miller F
J Pediatr Orthop; 2018; 38(10):e610-e617. PubMed ID: 30134351
[TBL] [Abstract][Full Text] [Related]
34. Radiation dose reduction for CT-guided intrathecal nusinersen administration in adult patients with spinal muscular atrophy.
Cordts I; Deschauer M; Lingor P; Burian E; Baum T; Zimmer C; Maegerlein C; Sollmann N
Sci Rep; 2020 Feb; 10(1):3406. PubMed ID: 32099042
[TBL] [Abstract][Full Text] [Related]
35. Nusinersen by subcutaneous intrathecal catheter for symptomatic spinal muscular atrophy patients with complex spine anatomy.
Carson VJ; Young M; Brigatti KW; Robinson DL; Reed RM; Sohn J; Petrillo M; Farwell W; Miller F; Strauss KA
Muscle Nerve; 2022 Jan; 65(1):51-59. PubMed ID: 34606118
[TBL] [Abstract][Full Text] [Related]
36. Safety and Treatment Effects of Nusinersen in Longstanding Adult 5q-SMA Type 3 - A Prospective Observational Study.
Walter MC; Wenninger S; Thiele S; Stauber J; Hiebeler M; Greckl E; Stahl K; Pechmann A; Lochmüller H; Kirschner J; Schoser B
J Neuromuscul Dis; 2019; 6(4):453-465. PubMed ID: 31594243
[TBL] [Abstract][Full Text] [Related]
37. Radiation exposure of image-guided intrathecal administration of nusinersen to adult patients with spinal muscular atrophy.
Oldenburg D; Guberina N; Stolte B; Kizina K; Stenzel E; Radbruch A; Kleinschnitz C; Hagenacker T; Forsting M; Mönninghoff C
Neuroradiology; 2019 May; 61(5):565-574. PubMed ID: 30868184
[TBL] [Abstract][Full Text] [Related]
38. Transforaminal lumbar puncture for intrathecal access: Case series with literature review and comparison to other techniques.
Velayudhan V; Patel S; Danziger A; Grigorian A; Waite S; Efendizade A
J Clin Neurosci; 2020 Feb; 72():114-118. PubMed ID: 31980274
[TBL] [Abstract][Full Text] [Related]
39. Intrathecal administration of nusinersen in adolescent and adult SMA type 2 and 3 patients.
Wurster CD; Winter B; Wollinsky K; Ludolph AC; Uzelac Z; Witzel S; Schocke M; Schneider R; Kocak T
J Neurol; 2019 Jan; 266(1):183-194. PubMed ID: 30460449
[TBL] [Abstract][Full Text] [Related]
40. Transforaminal Lumbar Puncture: An Alternative Technique in Patients with Challenging Access.
Nascene DR; Ozutemiz C; Estby H; McKinney AM; Rykken JB
AJNR Am J Neuroradiol; 2018 May; 39(5):986-991. PubMed ID: 29567652
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
